
Our most successful splice yet. Subject H-48 AKA Ginger, a combination of piscis, simianus, aves, and many other genomes, has survived longer than any other specimen and is showing the most stable bioinformatics. With a high survivability index, Ginger may well live long enough to pair-mate with a male subject that we will create in phase two of the experiment.
Elsa got interviewed about our major success with gene-spliced organisms Fred and Ginger. I shot some of the conversation — she’s got some major zingers. Elsa-isms, i’m calling them. Here’s an excerpt, it’s my favorite bit.

These screens show the gestation of a spliced organism — in this case, “Ginger” — inside the gestation device BETI. It looks like a sonogram because it IS a sonogram. BETI is in every way identical to an actual womb, but remapped with biomechanical technology. This is an organism that has never before existed on the planet Earth. You’re looking at the first baby pictures of the future!
The lab always has a soundtrack. Sometimes we crank it out to metal; sometimes we dance to free jazz. On special occasions we like to listen to interpolated music — old favorites tossed into software that breaks the music down to a “genome” and recombines it into a new audio experience. The following are a few of our favorite interpolations.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.

Nucleic Exchange Research and Development
is a laboratory dedicated to pushing the forefront of genetic science. Founded by Transgenic Developers Elsa Kast and Clive Nicoli, and funded by the research division of Newstead Pharma, N.E.R.D. is focusing on gene splicing and protein production.
By splicing together the DNA of various species into new organisms, we are attempting to isolate entirely new proteins that can be used in a variety of medicinal contexts.
Our research and our experimentation results are available to the specialized science community. This website is an experimental attempt to communicate with the larger population of scientists, thinkers, and anyone who might be interested in taking a look at the future of life sciences and bioengineering.
What are our end goals? To bend DNA technology entirely to the will of science and bioengineering, to create new forms of life, to cure most known diseases— to go forth, with science, and SAVE THE WORLD.
